People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotech / Pharma, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PharmacoPhotonics, Inc. | — | Biotech / Pharma | Series A | $16.6M | $217.9M | 2009 |
| Sonarmed Inc | — | Other Health Care | Seed | $9.1M | $61.5M | 2012 |
| Anagin, Inc. | — | Pharmaceuticals | Seed | $4.4M | $49.8M | 2016 |
Nora Doherty at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nora Doherty on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ken Green | 1 | 7 |
| Oscar Moralez | 1 | 6 |
| Gregory B. Brown | 1 | 4 |
| Derek Small | 1 | 4 |
| Fred McClure | 1 | 3 |
| Andrew D. Cothrel | 1 | 3 |
| James Schulz | 1 | 3 |
| Fritz French | 1 | 2 |
| Mark Leyerle | 1 | 2 |
| David Gunn | 1 | 2 |
| Mark E. Leyerle | 1 | 2 |
| Robert McDonald | 1 | 2 |
| James Tyree | 1 | 2 |
| David Wortman | 1 | 2 |
| Tom Bumgardner | 1 | 2 |
| Dennert Ware | 1 | 2 |
| Jane D. Martin | 1 | 1 |
| Eduardo Juan | 1 | 1 |
| Jeff Mansfield | 1 | 1 |
| Nora D. Doherty | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.